301171518	O	O
208036	O	O
IMGCTT	O	O
CT	O	O
THORAX	O	O
CT	O	O
SCAN	O	O
OF	O	O
THE	O	O
THORAX	O	O
,	O	O
NOVEMBER	O	O
21	O	O
,	O	O
2005	O	O
:	O	O
COMPARISON	O	O
:	O	O
Comparison	O	O
is	O	O
made	O	O
with	O	O
November	O	O
3	O	O
,	O	O
2005	O	O
.	O	O
CLINICAL	O	O
HISTORY	O	O
:	O	O
69-year-old	O	O
female	O	O
status	O	O
post	O	O
total	O	O
arch	O	O
replacement	O	O
with	O	O
elephant	O	O
trunk	O	O
and	O	O
re-implantation	O	O
of	O	O
the	O	O
supra	O	O
-	O	O
aortic	O	O
vessels	O	O
.	O	O
TECHNIQUE	O	O
:	O	O
Standard	O	O
CT	O	O
of	O	O
the	O	O
thorax	O	O
was	O	O
performed	O	O
without	O	O
intravenous	O	O
contrast	O	O
with	O	O
5	O	O
mm	O	O
and	O	O
1.25	O	O
mm	O	O
slice	O	O
thickness	O	O
.	O	O
FINDINGS	O	O
:	O	O
This	O	O
is	O	O
a	O	O
limited	3_Yellow_Days	O
non-contrast	3_Yellow_Days	O
evaluation	3_Yellow_Days	O
.	O	O
There	O	O
are	O	O
stable	3_Yellow_Days	O
post	3_Yellow_Days	O
-	3_Yellow_Days	O
surgical	3_Yellow_Days	O
changes	3_Yellow_Days	O
after	3_Yellow_Days	O
aortic	3_Yellow_Days	O
repair	3_Yellow_Days	O
with	3_Yellow_Days	O
a	3_Yellow_Days	O
ascending	3_Yellow_Days	O
aortic	3_Yellow_Days	3_Yellow_Days
and	3_Yellow_Days	3_Yellow_Days
transverse	3_Yellow_Days	3_Yellow_Days
aortic	3_Yellow_Days	3_Yellow_Days
graft	3_Yellow_Days	3_Yellow_Days
.	O	O
The	O	O
graft	O	O
extends	O	O
into	O	O
the	O	O
brachicephalic	O	O
artery	O	O
and	O	O
the	O	O
left	O	3_Yellow_Days
common	O	3_Yellow_Days
carotid	O	3_Yellow_Days
and	O	3_Yellow_Days
left	O	O
subclavian	O	O
arteries	O	O
have	O	O
been	O	O
re-implanted	O	O
.	O	O
Stable	3_Yellow_Days	O
appearance	3_Yellow_Days	O
in	3_Yellow_Days	O
position	3_Yellow_Days	O
of	3_Yellow_Days	O
an	3_Yellow_Days	O
endograft	3_Yellow_Days	3_Yellow_Days
within	3_Yellow_Days	3_Yellow_Days
the	3_Yellow_Days	3_Yellow_Days
distal	3_Yellow_Days	3_Yellow_Days
transverse	3_Yellow_Days	3_Yellow_Days
thoracic	3_Yellow_Days	O
aorta	3_Yellow_Days	O
extending	3_Yellow_Days	O
into	3_Yellow_Days	O
the	3_Yellow_Days	O
proximal	3_Yellow_Days	O
descending	3_Yellow_Days	O
thoracic	3_Yellow_Days	O
aorta	3_Yellow_Days	O
without	O	O
evidence	O	O
of	O	O
graft	O	O
discontinuity	O	O
.	O	O
There	O	O
are	O	O
evolving	3_Yellow_Days	O
post-surgical	3_Yellow_Days	O
changes	3_Yellow_Days	O
within	3_Yellow_Days	O
the	3_Yellow_Days	O
mediastinum	3_Yellow_Days	O
with	3_Yellow_Days	O
decreased	3_Yellow_Days	O
amount	3_Yellow_Days	O
of	3_Yellow_Days	O
mediastinal	3_Yellow_Days	O
hematoma	3_Yellow_Days	O
.	O	O
There	O	O
is	O	O
low	3_Yellow_Days	O
density	3_Yellow_Days	O
fluid	3_Yellow_Days	O
positioned	3_Yellow_Days	O
along	3_Yellow_Days	O
the	3_Yellow_Days	O
medial	3_Yellow_Days	O
aspect	3_Yellow_Days	O
of	3_Yellow_Days	O
the	3_Yellow_Days	O
aortic	3_Yellow_Days	O
arch	3_Yellow_Days	O
and	3_Yellow_Days	O
within	3_Yellow_Days	O
the	3_Yellow_Days	O
AP	3_Yellow_Days	O
window	3_Yellow_Days	O
which	O	O
deviates	O	O
the	O	O
trachea	O	O
and	O	O
esophagus	O	O
to	O	O
the	O	O
right	O	O
consisting	3_Yellow_Days	O
with	3_Yellow_Days	O
known	3_Yellow_Days	O
evolving	3_Yellow_Days	O
mediastinal	3_Yellow_Days	O
hematoma	3_Yellow_Days	O
.	O	O
The	O	O
previously	3_Yellow_Days	O
noted	3_Yellow_Days	O
pericardial	3_Yellow_Days	3_Yellow_Days
effusion	3_Yellow_Days	3_Yellow_Days
has	3_Yellow_Days	3_Yellow_Days
decreased	3_Yellow_Days	3_Yellow_Days
in	3_Yellow_Days	3_Yellow_Days
size	3_Yellow_Days	3_Yellow_Days
and	3_Yellow_Days	3_Yellow_Days
there	3_Yellow_Days	O
is	3_Yellow_Days	O
now	3_Yellow_Days	O
only	3_Yellow_Days	O
a	3_Yellow_Days	O
small	3_Yellow_Days	3_Yellow_Days
residual	3_Yellow_Days	3_Yellow_Days
pericardial	3_Yellow_Days	3_Yellow_Days
effusion	3_Yellow_Days	3_Yellow_Days
.	O	O
Persistent	3_Yellow_Days	3_Yellow_Days
moderate	3_Yellow_Days	3_Yellow_Days
to	3_Yellow_Days	3_Yellow_Days
large	3_Yellow_Days	3_Yellow_Days
bilateral	3_Yellow_Days	3_Yellow_Days
pleural	3_Yellow_Days	3_Yellow_Days
effusions	3_Yellow_Days	3_Yellow_Days
.	O	O
There	O	O
is	O	O
limited	O	O
evaluation	O	O
of	O	O
the	O	O
pulmonary	O	O
parenchyma	O	O
secondary	O	O
to	O	O
patient	O	O
motion	O	O
but	O	O
there	O	O
is	O	O
atelectasis	O	O
noted	O	O
in	O	O
the	O	O
left	O	O
upper	O	O
lobe	O	O
,	O	O
left	O	3_Yellow_Days
lower	O	3_Yellow_Days
lobe	O	3_Yellow_Days
,	O	3_Yellow_Days
and	O	3_Yellow_Days
right	O	3_Yellow_Days
lower	O	3_Yellow_Days
lobe	O	3_Yellow_Days
.	O	O
There	3_Yellow_Days	O
are	3_Yellow_Days	O
more	3_Yellow_Days	3_Yellow_Days
ill	3_Yellow_Days	O
-	3_Yellow_Days	O
defined	3_Yellow_Days	3_Yellow_Days
patchy	3_Yellow_Days	3_Yellow_Days
areas	3_Yellow_Days	3_Yellow_Days
of	3_Yellow_Days	3_Yellow_Days
parenchymal	3_Yellow_Days	3_Yellow_Days
opacity	3_Yellow_Days	3_Yellow_Days
which	3_Yellow_Days	O
have	3_Yellow_Days	O
developed	3_Yellow_Days	O
since	3_Yellow_Days	O
the	3_Yellow_Days	O
prior	3_Yellow_Days	O
scan	3_Yellow_Days	O
within	3_Yellow_Days	O
the	3_Yellow_Days	O
periphery	3_Yellow_Days	3_Yellow_Days
of	3_Yellow_Days	3_Yellow_Days
the	3_Yellow_Days	3_Yellow_Days
right	3_Yellow_Days	3_Yellow_Days
upper	3_Yellow_Days	3_Yellow_Days
lobe	3_Yellow_Days	3_Yellow_Days
,	3_Yellow_Days	3_Yellow_Days
middle	3_Yellow_Days	3_Yellow_Days
lobe	3_Yellow_Days	3_Yellow_Days
and	3_Yellow_Days	3_Yellow_Days
anterior	3_Yellow_Days	3_Yellow_Days
right	3_Yellow_Days	3_Yellow_Days
lower	3_Yellow_Days	3_Yellow_Days
lobe	3_Yellow_Days	3_Yellow_Days
which	3_Yellow_Days	O
are	3_Yellow_Days	O
non-specific	3_Yellow_Days	O
.	O	O
Right	O	O
internal	O	O
jugular	O	O
venous	O	O
catheter	O	O
with	O	O
the	O	O
tip	O	O
in	O	O
the	O	O
distal	O	O
superior	O	O
vena	O	O
cava	O	O
.	O	O
Limited	O	O
non-contrast	O	O
evaluation	O	O
of	O	O
the	O	O
upper	O	O
abdomen	O	O
demonstrates	O	O
abdominal	3_Yellow_Days	O
ascites	3_Yellow_Days	O
and	O	O
diffuse	O	O
infiltration	O	O
of	O	O
the	O	O
abdominal	O	O
wall	O	O
subcutaneous	O	O
tissue	O	O
and	O	O
musculature	O	O
consistent	O	O
with	O	O
diffuse	3_Yellow_Days	O
anasarca	3_Yellow_Days	O
.	O	O
Evaluation	O	O
of	O	O
the	O	O
bony	O	O
structures	O	O
demonstrates	O	O
post-surgical	O	O
changes	O	O
status	O	O
post	O	O
median	O	O
sternotomy	O	O
IMPRESSION	O	O
:	O	O
1	O	O
.	O	O
LIMITED	O	O
NON-CONTRAST	O	O
CT	O	O
OF	O	O
THE	O	O
THORAX	O	O
DEMONSTRATES	O	O
GROSSLY	O	O
STABLE	3_Yellow_Days	O
POST-OPERATIVE	3_Yellow_Days	O
APPEARANCE	3_Yellow_Days	O
AFTER	3_Yellow_Days	O
ASCENDING	3_Yellow_Days	O
AND	3_Yellow_Days	O
TRANSVERSE	3_Yellow_Days	O
AORTIC	3_Yellow_Days	O
GRAFT	3_Yellow_Days	O
WITH	O	O
RE-IMPLANTATION	O	O
OF	O	O
THE	O	O
SUPRA-AORTIC	O	O
VESSELS	O	O
.	O	O
STABLE	3_Yellow_Days	O
APPEARANCE	3_Yellow_Days	O
AND	3_Yellow_Days	O
POSITION	3_Yellow_Days	O
OF	3_Yellow_Days	O
AN	3_Yellow_Days	O
ENDOGRAFT	3_Yellow_Days	O
IN	3_Yellow_Days	O
THE	3_Yellow_Days	O
DISTAL	3_Yellow_Days	O
TRANSVERSE	3_Yellow_Days	O
AORTIC	3_Yellow_Days	O
ARCH	3_Yellow_Days	O
EXTENDING	O	O
INTO	O	O
THE	O	O
PROXIMAL	O	O
DESCENDING	O	O
THORACIC	O	O
AORTA	O	O
.	O	O
2	O	O
.	O	O
EVOLVING	3_Yellow_Days	O
POST-OPERATIVE	3_Yellow_Days	O
MEDIASTINAL	3_Yellow_Days	O
HEMATOMA	3_Yellow_Days	O
AND	3_Yellow_Days	O
INTERVAL	3_Yellow_Days	O
DECREASE	3_Yellow_Days	1_Red_Minutes
IN	3_Yellow_Days	O
SIZE	3_Yellow_Days	3_Yellow_Days
OF	3_Yellow_Days	3_Yellow_Days
PERICARDIAL	3_Yellow_Days	3_Yellow_Days
EFFUSION	3_Yellow_Days	3_Yellow_Days
.	O	O
2	O	O
.	O	O
PERSISTENT	3_Yellow_Days	3_Yellow_Days
BILATERAL	3_Yellow_Days	3_Yellow_Days
PLEURAL	3_Yellow_Days	3_Yellow_Days
EFFUSIONS	3_Yellow_Days	3_Yellow_Days
AND	O	O
ATELECTASIS	O	3_Yellow_Days
.	O	O
3	O	O
.	O	O
INTERVAL	1_Red_Minutes	3_Yellow_Days
DEVELOPMENT	1_Red_Minutes	3_Yellow_Days
OF	1_Red_Minutes	3_Yellow_Days
PATCHY	1_Red_Minutes	3_Yellow_Days
AREAS	1_Red_Minutes	3_Yellow_Days
OF	1_Red_Minutes	1_Red_Minutes
PARENCHYMAL	1_Red_Minutes	1_Red_Minutes
OPACITY	1_Red_Minutes	1_Red_Minutes
WITHIN	1_Red_Minutes	1_Red_Minutes
THE	1_Red_Minutes	1_Red_Minutes
RIGHT	1_Red_Minutes	1_Red_Minutes
UPPER	1_Red_Minutes	1_Red_Minutes
LOBE	1_Red_Minutes	1_Red_Minutes
,	1_Red_Minutes	1_Red_Minutes
RIGHT	1_Red_Minutes	1_Red_Minutes
MIDDLE	1_Red_Minutes	1_Red_Minutes
LOBE	1_Red_Minutes	1_Red_Minutes
,	1_Red_Minutes	1_Red_Minutes
AND	1_Red_Minutes	1_Red_Minutes
RIGHT	1_Red_Minutes	1_Red_Minutes
LOWER	1_Red_Minutes	1_Red_Minutes
LOBE	1_Red_Minutes	1_Red_Minutes
WHICH	1_Red_Minutes	O
MAY	1_Red_Minutes	O
REPRESENT	1_Red_Minutes	O
A	1_Red_Minutes	O
FOCUS	1_Red_Minutes	1_Red_Minutes
OF	1_Red_Minutes	O
INFECTION	1_Red_Minutes	O
,	1_Red_Minutes	O
ASPIRATION	1_Red_Minutes	O
OR	1_Red_Minutes	O
POSSIBLY	1_Red_Minutes	O
RESOLVING	1_Red_Minutes	O
ASYMMETRIC	1_Red_Minutes	3_Yellow_Days
PULMONARY	1_Red_Minutes	3_Yellow_Days
EDEMA	1_Red_Minutes	3_Yellow_Days
.	O	O
CORRELATION	1_Red_Minutes	O
IS	1_Red_Minutes	O
RECOMMENDED	1_Red_Minutes	O
.	O	O
END	O	O
OF	O	O
IMPRESSION	O	O
:	O	O
SUMMARY	O	O
:	O	O
2	O	O
ABNORMAL	O	O
,	O	O
PREVIOUSLY	O	O
REPORTED	O	O
END	O	O
OF	O	O
IMPRESSION	O	O
:	O	O
I	O	O
have	O	O
personally	O	O
reviewed	O	O
the	O	O
images	O	O
for	O	O
this	O	O
examination	O	O
and	O	O
agree	O	O
with	O	O
the	O	O
report	O	O
transcribed	O	O
above	O	O
.	O	O
By	O	O
:	O	O
Jeffrey	O	O
Hellinger	O	O
,	O	O
M.D.	O	O
on	O	O
:	O	O
11/22/2005	O	O
20:24	O	O
003.1	O	O
038.8	O	O
136.9	O	O
218.9	O	O
276.1	O	O
276.2	O	O
285.1	O	O
285.9	O	O
286.9	O	O
288.0	O	O
71250	O	O
CT	O	O
CHEST	O	O
wo	O	O
CT	O	O
05/08/2007	O	O
Nonenhanced	O	O
chest	O	O
CT	O	O
shows	O	O
extensive	3_Yellow_Days	O
fibrosis	3_Yellow_Days	O
with	3_Yellow_Days	O
associated	3_Yellow_Days	O
honeycombing	3_Yellow_Days	O
and	3_Yellow_Days	O
traction	3_Yellow_Days	O
bronchiectasis	3_Yellow_Days	O
in	3_Yellow_Days	O
the	3_Yellow_Days	O
periphery	3_Yellow_Days	O
and	3_Yellow_Days	O
bases	3_Yellow_Days	3_Yellow_Days
of	3_Yellow_Days	3_Yellow_Days
both	3_Yellow_Days	3_Yellow_Days
lungs	3_Yellow_Days	3_Yellow_Days
.	O	O
The	O	O
findings	O	O
have	O	O
progressed	O	O
moderately	O	O
since	O	O
9/27/05	O	O
.	O	O
Marked	3_Yellow_Days	O
enlargement	3_Yellow_Days	O
of	3_Yellow_Days	O
the	3_Yellow_Days	O
central	3_Yellow_Days	O
pulmonary	3_Yellow_Days	O
arteries	3_Yellow_Days	O
due	3_Yellow_Days	O
to	3_Yellow_Days	3_Yellow_Days
pulmonary	3_Yellow_Days	3_Yellow_Days
arterial	3_Yellow_Days	3_Yellow_Days
hypertension	3_Yellow_Days	3_Yellow_Days
.	O	O
Calcified	O	O
right	O	O
hilar	O	O
and	O	O
mediastinal	O	O
nodes	O	O
with	O	O
calcified	O	O
granulomas	O	O
in	O	O
the	O	O
liver	O	O
and	O	O
spleen	O	O
.	O	O
Extensive	O	3_Yellow_Days
coronary	O	3_Yellow_Days
artery	O	3_Yellow_Days
calcification	O	3_Yellow_Days
.	O	O
Tiny	3_Yellow_Days	3_Yellow_Days
calculi	3_Yellow_Days	O
in	3_Yellow_Days	O
the	3_Yellow_Days	O
right	3_Yellow_Days	O
kidney	3_Yellow_Days	O
.	O	O
Generous	O	O
adrenal	O	O
glands	O	O
without	O	O
discrete	O	O
mass	O	O
.	O	O
302497186	O	O
22320	O	O
IMGCTT	O	O
CT	O	O
THORAX	O	O
CT	O	O
OF	O	O
THE	O	O
CHEST	O	O
:	O	O
05/22/2002	O	O
.	O	O
COMPARISON	O	O
:	O	O
Outside	O	O
CT	O	O
's	O	O
from	O	O
the	O	O
Hospital	O	O
of	O	O
the	O	O
University	O	O
of	O	O
Pennsylvania	O	O
,	O	O
dated	O	O
04/03/2002	O	O
and	O	O
02/12/2002	O	O
,	O	O
labelled	O	O
with	O	O
the	O	O
patient	O	O
's	O	O
name	O	O
.	O	O
Additional	O	O
comparison	O	O
is	O	O
made	O	O
to	O	O
a	O	O
CT	O	O
of	O	O
the	O	O
chest	O	O
from	O	O
this	O	O
institution	O	O
,	O	O
dated	O	O
01/07/2002	O	O
.	O	O
TECHNIQUE	O	O
:	O	O
Spiral	O	O
CT	O	O
acquisition	O	O
through	O	O
the	O	O
chest	O	O
,	O	O
without	O	O
intravenous	O	O
contrast	O	O
at	O	O
2	O	O
mm	O	O
slice	O	O
thickness	O	O
.	O	O
FINDINGS	O	O
:	O	O
The	O	O
comparisons	O	O
to	O	O
the	O	O
examinations	O	O
from	O	O
the	O	O
Hospital	O	O
of	O	O
the	O	O
University	O	O
of	O	O
Pennsylvania	O	O
are	O	O
of	O	O
limited	O	O
value	O	O
,	O	O
as	O	O
no	O	O
lung	O	O
windows	O	O
are	O	O
included	O	O
.	O	O
I	O	O
am	O	O
able	O	O
to	O	O
compare	O	O
from	O	O
the	O	O
lung	O	O
windows	O	O
from	O	O
the	O	O
study	O	O
at	O	O
this	O	O
institution	O	O
from	O	O
01/07/2002	O	O
.	O	O
There	O	O
as	O	O
been	O	O
marked	3_Yellow_Days	O
interval	3_Yellow_Days	O
improvement	3_Yellow_Days	O
in	3_Yellow_Days	O
the	3_Yellow_Days	O
bilateral	3_Yellow_Days	O
pulmonary	3_Yellow_Days	O
nodules	3_Yellow_Days	O
since	3_Yellow_Days	O
the	3_Yellow_Days	O
01/07/2002	3_Yellow_Days	O
examination	3_Yellow_Days	O
.	O	O
The	O	O
only	3_Yellow_Days	O
nodule	3_Yellow_Days	O
remaining	3_Yellow_Days	O
is	3_Yellow_Days	O
a	3_Yellow_Days	O
3	3_Yellow_Days	3_Yellow_Days
mm	3_Yellow_Days	3_Yellow_Days
nodule	3_Yellow_Days	3_Yellow_Days
in	3_Yellow_Days	O
the	3_Yellow_Days	O
right	3_Yellow_Days	O
upper	3_Yellow_Days	O
lobe	3_Yellow_Days	O
on	O	O
image	O	O
no.	O	O
60	O	O
of	O	O
series	O	O
3	O	O
,	O	O
which	O	O
is	O	O
stable	O	O
since	O	O
01/07/2002	O	O
.	O	O
No	O	O
pleural	O	O
or	O	O
pericardial	O	O
effusions	O	O
.	O	O
No	O	O
enlarged	O	O
axillary	O	O
,	O	O
hilar	O	O
or	O	O
mediastinal	O	O
lymph	O	O
nodes	O	O
are	O	O
identified	O	O
.	O	O
The	O	O
visualized	O	O
upper	O	O
abdominal	O	O
viscera	O	O
have	O	O
a	O	O
unremarkable	O	O
non-contrast	O	O
appearance	O	O
.	O	O
Review	O	O
of	O	O
skeletal	O	O
structures	O	O
does	O	O
not	O	O
reveal	O	O
any	O	O
suspicious	O	O
lytic	O	O
or	O	O
blastic	O	O
lesions	O	O
.	O	O
IMPRESSION	O	O
:	O	O
1	O	O
.	O	O
MARKED	3_Yellow_Days	1_Red_Minutes
INTERVAL	3_Yellow_Days	1_Red_Minutes
DECREASE	3_Yellow_Days	1_Red_Minutes
IN	3_Yellow_Days	1_Red_Minutes
BILATERAL	3_Yellow_Days	3_Yellow_Days
PULMONARY	3_Yellow_Days	3_Yellow_Days
NODULES	3_Yellow_Days	3_Yellow_Days
.	O	O
ONLY	3_Yellow_Days	O
A	3_Yellow_Days	O
3	3_Yellow_Days	3_Yellow_Days
MM	3_Yellow_Days	3_Yellow_Days
RIGHT	3_Yellow_Days	3_Yellow_Days
UPPER	3_Yellow_Days	O
LOBE	3_Yellow_Days	O
NODULE	3_Yellow_Days	O
REMAINS	3_Yellow_Days	O
SINCE	O	O
01/07/2002	O	O
,	O	O
AND	O	O
THIS	3_Yellow_Days	O
NODULE	3_Yellow_Days	3_Yellow_Days
IS	3_Yellow_Days	O
STABLE	3_Yellow_Days	3_Yellow_Days
SINCE	O	O
THAT	O	O
TIME	O	O
.	O	O
2	O	O
.	O	O
NO	O	O
EVIDENCE	O	O
OF	O	O
ENLARGED	O	O
LYMPH	O	O
NODES	O	O
IN	O	O
THE	O	O
CHEST	O	O
.	O	O
END	O	O
OF	O	O
IMPRESSION	O	O
:	O	O
SUMMARY	O	O
:	O	O
2	O	O
038.9	O	O
078.5	O	O
079.99	O	O
117.3	O	O
136.9	O	O
141.4	O	O
200.02	O	O
200.10	O	O
200.12	O	O
201.00	O	O
407782373	O	O
407013	O	O
IMGCTTW	O	O
CT	O	O
THORAX	O	O
W	O	O
CONTRAST	O	O
IMPRESSION	O	O
:	O	O
EXAM	O	O
:	O	O
CT	O	O
Thorax	O	O
with	O	O
contrast	O	O
10/8/2012	O	O
8:54	O	O
AM	O	O
CLINICAL	O	O
HISTORY	O	O
:	O	O
45-year-old	O	O
woman	O	O
with	O	O
fatigue	O	O
,	O	O
dizziness	O	O
,	O	O
1	O	O
.	O	O
NO	O	O
EVIDENCE	O	O
OF	O	O
THYMOMA	O	O
hypotension	O	O
and	O	O
positive	O	O
striated	O	O
muscle	O	O
antibody	O	O
,	O	O
referred	O	O
for	O	O
consideration	O	O
of	O	O
thymoma	O	O
.	O	O
2	O	O
.	O	O
NONSPECIFIC	3_Yellow_Days	3_Yellow_Days
LINEAR	3_Yellow_Days	3_Yellow_Days
CLUSTER	3_Yellow_Days	3_Yellow_Days
OF	3_Yellow_Days	3_Yellow_Days
2-MM	3_Yellow_Days	3_Yellow_Days
NODULES	3_Yellow_Days	3_Yellow_Days
IN	3_Yellow_Days	3_Yellow_Days
THE	3_Yellow_Days	3_Yellow_Days
LATERAL	3_Yellow_Days	3_Yellow_Days
BASAL	3_Yellow_Days	3_Yellow_Days
RIGHT	3_Yellow_Days	3_Yellow_Days
LOWER	3_Yellow_Days	3_Yellow_Days
LOBE	3_Yellow_Days	3_Yellow_Days
,	3_Yellow_Days	O
WHICH	3_Yellow_Days	O
MAY	3_Yellow_Days	O
REPRESENT	3_Yellow_Days	O
SEQUELA	3_Yellow_Days	O
OF	3_Yellow_Days	O
PRIOR	3_Yellow_Days	O
INFECTION	3_Yellow_Days	O
.	O	O
IF	O	O
THE	O	O
PATIENT	O	O
IS	O	O
NOT	O	O
AT	O	O
ELEVATED	O	O
RISK	O	O
FOR	O	O
LUNG	O	O
CANCER	O	O
,	O	O
SUCH	O	O
AS	O	O
HISTORY	O	O
COMPARISON	O	O
:	O	O
None	O	O
OF	O	O
SMOKING	O	O
,	O	O
NO	O	O
FURTHER	O	O
CT	O	O
FOLLOW-UP	O	O
IMAGING	O	O
IS	O	O
NECESSARY	O	O
.	O	O
TECHNIQUE	O	O
:	O	O
Volumetric	O	O
acquisition	O	O
was	O	O
obtained	O	O
from	O	O
the	O	O
lung	O	O
apex	O	O
through	O	O
the	O	O
upper	O	O
abdomen	O	O
following	O	O
intravenous	O	O
administration	O	O
of	O	O
SUMMARY	O	O
:4	O	O
-	O	O
POSSIBLY	O	O
SIGNIFICANT	O	O
FINDING	O	O
,	O	O
MAY	O	O
NEED	O	O
ACTION	O	O
contrast	O	O
-LRB-	O	O
88-ML	O	O
of	O	O
Omnipaque	O	O
350	O	O
-RRB-	O	O
.	O	O
Data	O	O
were	O	O
reconstructed	O	O
at	O	O
contiguous	O	O
1	O	O
mm	O	O
and	O	O
5	O	O
mm	O	O
section	O	O
thicknesses	O	O
.	O	O
Sagittal	O	O
,	O	O
coronal	O	O
and	O	O
maximum	O	O
intensity	O	O
projection	O	O
reformations	O	O
were	O	O
performed	O	O
.	O	O
Based	O	O
on	O	O
a	O	O
32	O	O
cm	O	O
body	O	O
phantom	O	O
,	O	O
the	O	O
estimated	O	O
radiation	O	O
dose	O	O
-LRB-	O	O
CTDIvol	O	O
-LSB-	O	O
mGy	O	O
-RSB-	O	O
-RRB-	O	O
for	O	O
each	O	O
series	O	O
in	O	O
this	O	O
exam	O	O
is	O	O
:	O	O
4.27	O	O
.	O	O
The	O	O
estimated	O	O
cumulative	O	O
dose	O	O
-LRB-	O	O
DLP	O	O
-LSB-	O	O
mGy-cm	O	O
-RSB-	O	O
-RRB-	O	O
is	O	O
:	O	O
153	O	O
.	O	O
NOTE	O	O
:	O	O
The	O	O
radiation	O	O
dose	O	O
indicators	O	O
for	O	O
CT	O	O
--	O	O
the	O	O
'	O	O
volume	O	O
CT	O	O
Dose	O	O
Index	O	O
'	O	O
-LRB-	O	O
CTDIvol	O	O
-RRB-	O	O
given	O	O
in	O	O
milli-Gray	O	O
-LRB-	O	O
mGy	O	O
-RRB-	O	O
,	O	O
and	O	O
the	O	O
Dose	O	O
Length	O	O
Product	O	O
-LRB-	O	O
DLP	O	O
-RRB-	O	O
given	O	O
in	O	O
mGy-centimeters	O	O
-LRB-	O	O
mGy.cm	O	O
-RRB-	O	O
--	O	O
are	O	O
generated	O	O
from	O	O
the	O	O
CT	O	O
scanner	O	O
to	O	O
estimate	O	O
radiation	O	O
exposure	O	O
based	O	O
on	O	O
technical	O	O
study	O	O
parameters	O	O
and	O	O
a	O	O
reference	O	O
phantom	O	O
.	O	O
The	O	O
CTDI	O	O
and	O	O
DLP	O	O
may	O	3_Yellow_Days
therefore	O	O
substantially	O	O
over	O	O
-	O	O
or	O	O
underestimate	O	O
an	O	O
individual	O	O
's	O	O
absorbed	O	O
dose	O	O
based	O	O
on	O	O
patient	O	O
size	O	O
and	O	O
other	O	O
factors	O	O
.	O	O
FINDINGS	O	O
:	O	O
The	O	O
visualized	O	O
portions	O	O
of	O	O
the	O	O
thyroid	O	O
gland	O	O
are	O	O
unremarkable	O	O
.	O	O
No	O	O
mediastinal	O	O
mass	O	O
that	O	O
indicates	O	O
presence	O	O
of	O	O
thymoma	O	O
.	O	O
Five	3_Yellow_Days	O
pulmonary	3_Yellow_Days	3_Yellow_Days
nodules	3_Yellow_Days	3_Yellow_Days
measuring	3_Yellow_Days	O
up	3_Yellow_Days	3_Yellow_Days
to	3_Yellow_Days	3_Yellow_Days
2	3_Yellow_Days	3_Yellow_Days
mm	3_Yellow_Days	3_Yellow_Days
in	3_Yellow_Days	3_Yellow_Days
a	3_Yellow_Days	3_Yellow_Days
linear	3_Yellow_Days	3_Yellow_Days
distribution	3_Yellow_Days	3_Yellow_Days
are	3_Yellow_Days	O
present	3_Yellow_Days	O
in	3_Yellow_Days	O
the	3_Yellow_Days	O
lateral	3_Yellow_Days	3_Yellow_Days
basal	3_Yellow_Days	3_Yellow_Days
right	3_Yellow_Days	3_Yellow_Days
lower	3_Yellow_Days	3_Yellow_Days
lobe	3_Yellow_Days	3_Yellow_Days
-LRB-	3_Yellow_Days	O
series	3_Yellow_Days	O
3	O	O
,	O	O
images	O	O
185	O	O
through	O	O
188	O	O
-RRB-	O	O
.	O	O
A	O	O
pleural-based	O	1_Red_Minutes
opacity	O	1_Red_Minutes
measuring	O	O
3	O	3_Yellow_Days
mm	O	3_Yellow_Days
in	O	3_Yellow_Days
the	O	3_Yellow_Days
posterior	O	3_Yellow_Days
right	O	3_Yellow_Days
upper	O	3_Yellow_Days
lobe	O	3_Yellow_Days
likely	O	3_Yellow_Days
represents	O	O
small	O	O
amount	O	O
of	O	O
atelectasis	O	O
.	O	O
No	O	O
pleural	O	O
effusions	O	O
.	O	O
The	O	O
airways	O	O
are	O	O
patent	O	O
and	O	O
of	O	O
normal	O	O
course	O	O
and	O	O
caliber	O	O
.	O	O
The	O	O
heart	O	O
size	O	O
is	O	O
normal	O	O
without	O	O
pericardial	O	O
effusion	O	O
.	O	O
The	O	O
aorta	O	O
is	O	O
normal	O	O
in	O	O
course	O	O
and	O	O
caliber	O	O
.	O	O
Coronary	O	3_Yellow_Days
artery	O	3_Yellow_Days
calcifications	O	3_Yellow_Days
are	O	O
not	O	3_Yellow_Days
present	O	3_Yellow_Days
.	O	O
The	O	O
main	O	O
pulmonary	O	O
artery	O	O
is	O	O
normal	O	O
in	O	O
course	O	O
and	O	O
caliber	O	O
.	O	O
While	O	O
not	O	3_Yellow_Days
a	O	O
dedicated	O	O
pulmonary	O	O
embolism	O	O
study	O	O
,	O	O
no	O	O
filling	O	O
defects	O	O
are	O	O
seen	O	O
in	O	O
the	O	O
main	O	3_Yellow_Days
or	O	3_Yellow_Days
lobar	O	3_Yellow_Days
pulmonary	O	3_Yellow_Days
arteries	O	3_Yellow_Days
to	O	O
suggest	O	O
pulmonary	O	O
embolism	O	O
.	O	O
No	O	O
mediastinal	O	O
,	O	O
hilar	O	O
or	O	O
axillary	O	O
lymphadenopathy	O	O
.	O	O
Limited	O	O
evaluation	O	O
of	O	O
the	O	O
upper	O	O
abdomen	O	O
in	O	O
arterial	O	O
phase	O	O
is	O	O
unremarkable	O	O
.	O	O
No	O	O
suspicious	O	O
bony	O	O
lesions	O	O
identified	O	O
.	O	O
337.9	O	O
443.0	O	O
458.0	O	O
458.9	O	O
564.00	O	O
780.2	O	O
780.4	O	O
780.79	O	O
783.5	O	O
785.0	O	O

